Institutional investors purchased a net $3.9 thousand shares of NVGN during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 1.59% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 5.1 Thousand shares of Novogen Ltd
CITADEL ADVISORS LLC Bought 1.3 Thousand shares of Novogen Ltd
MARKETOCRACY CAPITAL MANAGEMENT ... Sold 200.00 shares of Novogen Ltd